Tauroursodeoxycholic Acid Protect Against Type 2 Diabetes Through Suppression of Pancreatic TBP-2 and Preservation of Thioredoxin Activity
Journal of Medicinal Chemistry and Therapeutics · 25.07.2026 · 2 (01) · 0x-0x
DOI: 10.71193/jmct.20260012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry and Therapeutics, online erschienen am 25.07.2026. Verfasst von Ratan Hossain und 7 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Endoplasmic reticulum (ER) stress contributes to the development of type 2 diabetes mellitus (T2DM) by inducing thioredoxin-interacting protein (TXNIP/TBP-2), a key mediator of oxidative stress, mitochondrial dysfunction, and pancreatic β-cell injury. This study investigated whether tauroursodeoxycholic acid (TUDCA) and ursodeoxycholic acid (UDCA), two bile acids with ER stress–reducing properties, protect against T2DM through modulation of the pancreatic TBP-2/thioredoxin pathway. Combined TUDCA and UDCA supplementation markedly reduced diabetes incidence in high-fat diet (HFD)– and streptozotocin-induced diabetic rats (34% vs. 75% in untreated animals) and attenuated body weight gain. Mechanistically, rats protected from diabetes exhibited significantly lower pancreatic TBP-2 expression and reduced mitochondrial accumulation of TBP-2 compared with untreated diabetic rats. Preservation of both total and reduced thioredoxin activity was observed in supplemented animals, and thioredoxin activity was inversely associated with pancreatic and mitochondrial TBP-2 levels. These findings indicate that suppression of TBP-2 expression and inhibition of its mitochondrial translocation are closely linked to improved pancreatic redox homeostasis and resistance to diabetes development. In conclusion, TUDCA and UDCA protect against diabetogenesis by limiting TBP-2–mediated oxidative stress and preserving thioredoxin function, identifying the TBP-2/thioredoxin axis as a potential therapeutic target for T2DM.
Zitieren
APA
Hossain, R., Dutta, K. K., Bhowmick, A., Banerjee, P. K., Hossain, M. T., Biswas, C., Yasmin, M. T., & Khatun, M. M. (2026). Tauroursodeoxycholic Acid Protect Against Type 2 Diabetes Through Suppression of Pancreatic TBP-2 and Preservation of Thioredoxin Activity. Journal of Medicinal Chemistry and Therapeutics, 2(01), 0x-0x. https://doi.org/10.71193/jmct.20260012
Vancouver
Hossain R, Dutta KK, Bhowmick A, Banerjee PK, Hossain MT, Biswas C, et al. Tauroursodeoxycholic Acid Protect Against Type 2 Diabetes Through Suppression of Pancreatic TBP-2 and Preservation of Thioredoxin Activity. Journal of Medicinal Chemistry and Therapeutics. 2026;2(01):0x-0x. doi:10.71193/jmct.20260012
BibTeX
@article{Hossain2026,
author = {Hossain, Ratan and Dutta, Khokon Kumar and Bhowmick, Aitijjo and Banerjee, Probir Kumar and Hossain, Md. Tofazzal and Biswas, Choyan and Yasmin, Mst Tamanna and Khatun, Mst Muslima},
title = {Tauroursodeoxycholic Acid Protect Against Type 2 Diabetes Through Suppression of Pancreatic TBP-2 and Preservation of Thioredoxin Activity},
journal = {Journal of Medicinal Chemistry and Therapeutics},
year = {2026},
volume = {2},
number = {01},
pages = {0x--0x},
doi = {10.71193/jmct.20260012}
}
EUVIMED